株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マイコプラズマ検査の世界市場 〜2022年:製品&サービス・技術 (PCR・ELISA・酵素・DNA染色)・用途・エンドユーザー別

Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 330368
出版日 ページ情報 英文 158 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.89円で換算しております。
Back to Top
マイコプラズマ検査の世界市場 〜2022年:製品&サービス・技術 (PCR・ELISA・酵素・DNA染色)・用途・エンドユーザー別 Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User - Global Forecast to 2022
出版日: 2017年06月14日 ページ情報: 英文 158 Pages
概要

世界のマイコプラズマ検査市場は2017年から2022年にかけて12.5%のCAGR (年間複合成長率) で推移し、2022年には9億4340万米ドルの規模に成長すると予測されています。製薬・バイオテクノロジー産業に対する政府によるサポートの拡大、ライフサイエンス関連のR&Dの活発化、細胞培養における汚染の増加などの要因が同市場の成長を推進しています。

当レポートでは、世界のマイコプラズマ検査の市場を調査し、市場および検査の概要、市場成長への各種影響因子と市場機会の分析、製品&サービス・技術・用途・エンドユーザー・地域/主要国別の動向および市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 市場実績:地域・用途別
  • 市場の推移と予測:製品・サービス別
  • 地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題

第6章 市場分析:製品・サービス別

  • イントロダクション
  • キット&試薬
    • PCRアッセイ
    • 核酸検出キット
    • 除去キット・試薬
    • 染色液
    • スタンダート&コントロール
    • その他のキット&試薬
  • 器具
  • サービス

第7章 市場分析:技術別

  • イントロダクション
  • PCR
  • Elisa
  • 直接検査
  • 間接検査
  • DNA染色
  • 微生物培養法
  • 酵素的方法

第8章 市場分析:用途別

  • イントロダクション
  • 細胞株検査
  • ウイルス検査
  • EPC (End of Production Cells) 検査
  • その他

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • CRO
  • 学術研究機関
  • 細胞バンク
  • その他

第10章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スぺイン
    • その他
  • アジア
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域

第11章 競合環境

  • イントロダクション
  • VENDOR DIVE:概要
  • 競合ベンチマーキング

第12章 企業プロファイル

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • MERCK KGAA
  • LONZA GROUP LTD.
  • ROCHE DIAGNOSTICS (DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
  • SGS S.A.
  • THERMO FISHER SCIENTIFIC INC.
  • AMERICAN TYPE CULTURE COLLECTION
  • BIOUNIQUE TESTING LABORATORIES INC.
  • INVIVOGEN
  • PROMOCELL GMBH
  • BIOLOGICAL INDUSTRIES ISRAEL BEIT HAEMEK LTD.
  • WUXI APPTEC
  • NORGEN BIOTEK CORPORATION

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3371

The global mycoplasma testing market is expected to reach USD 943.4 million by 2022, at a CAGR of 12.5% from 2017 to 2022. The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination. On the other hand, the growth of this market is hindered to some extent due to the stringent regulatory framework & time-consuming approval processes and the high degree of consolidation which acts as an entry barrier for new companies.

Mycoplasma testing market to register the highest CAGR during the forecast period

On the basis of products, the mycoplasma testing market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to grow at a higher rate during the forecast period. This is attributed to the frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques.

Pharmaceutical and biotechnology companies to dominate the mycoplasma testing market during the forecast period

Based on end users, the mycoplasma testing market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. In 2017, pharmaceutical and biotechnology companies segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to the other segments. This can be attributed to the increasing R&D investments in the pharmaceutical industry.

Asia is estimated to be the fastest growing regional segment in the global mycoplasma testing market during the forecast period

Geographically, the mycoplasma testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 37%, Tier 2 - 47%, Tier 3-16%
  • By Designation - C level - 46%, Director level - 36%, Others - 18%
  • By Region - North America - 26%, Europe - 30%, APAC - 22%, South America - 13% and Middle East & Africa: 9%

The key players in the market are Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd., WuXi AppTec (U.S.), Norgen Biotek Corp. (Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (U.S.), GeneCopoeia, Inc. (U.S.), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (U.S.), Sartorius AG (Germany), Savyon Diagnostics (Israel), and ScienCell Research Laboratories, Inc. (Canada).

Study Coverage:

The report analyses the mycoplasma testing market by product, technique, application, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the mycoplasma testing market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the mycoplasma testing market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the mycoplasma testing market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various mycoplasma testing products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the mycoplasma testing market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MYCOPLASMA TESTING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: MYCOPLASMA TESTING MARKET, BY APPLICATION (2017)
  • 4.3. MYCOPLASMA TESTING MARKET, BY PRODUCT AND SERVICE, 2017-2022
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE MYCOPLASMA TESTING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing growth and government support for pharmaceutical and biotechnology industries
      • 5.2.1.2. Strong trend of R&D investments in life sciences
      • 5.2.1.3. Cell culture contamination-a major concern for laboratories
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High degree of consolidation acts as an entry barrier for new entrants
      • 5.2.2.2. Stringent regulatory frameworks and time-consuming approval processes for pharmaceutical and biotechnology companies
    • 5.2.3. OPPORTUNITY
      • 5.2.3.1. Increasing pharmaceutical outsourcing
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Shortage of skilled professionals

6. MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. KITS & REAGENTS
    • 6.2.1. PCR ASSAYS
    • 6.2.2. NUCLEIC ACID DETECTION KITS
    • 6.2.3. ELIMINATION KITS & REAGENTS
    • 6.2.4. STAINS
    • 6.2.5. STANDARDS & CONTROLS
    • 6.2.6. OTHER KITS & REAGENTS
  • 6.3. INSTRUMENTS
  • 6.4. SERVICES

7. MYCOPLASMA TESTING MARKET, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. PCR
  • 7.3. ELISA
  • 7.4. DIRECT ASSAYS
  • 7.5. INDIRECT ASSAYS
  • 7.6. DNA STAINING
  • 7.7. MICROBIAL CULTURE TECHNIQUES
  • 7.8. ENZYMATIC METHODS

8. MYCOPLASMA TESTING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CELL LINE TESTING
  • 8.3. VIRUS TESTING
  • 8.4. END-OF-PRODUCTION CELL TESTING
  • 8.5. OTHER APPLICATIONS

9. MYCOPLASMA TESTING MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.3. CONTRACT RESEARCH ORGANIZATIONS
  • 9.4. ACADEMIC RESEARCH INSTITUTES
  • 9.5. CELL BANKS
  • 9.6. OTHER END USERS

10. GEOGRAPHIC ANALYSIS

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. VENDOR DIVE OVERVIEW
    • 11.2.1. VANGUARDS
    • 11.2.2. INNOVATORS
    • 11.2.3. DYNAMIC
    • 11.2.4. EMERGING
  • 11.3. COMPETITIVE BENCHMARKING
    • 11.3.1. ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN MYCOPLASMA TETING MARKET (25 PLAYERS)
    • 11.3.2. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE MYCOPLASMA TESTING MARKET(25 PLAYERS)

Top 25 companies analyzed for this studies are - Charles River Laboratories International, Inc.(U.S.), Merck KGaA (Germany),Roche Diagnostics ( Switzerland), Lonza Group Ltd. (Switzerland), SGS S.A. (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.),InviVogen (U.S.), Promo Cell GMBH (Germany), Biological Industries Israel Beit Haemek Ltd, Wuxi AppTec.(U.S.), Norgen Biotek Corp.(Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A.(Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories(U.S.), GeneCopoeia Inc.(U.S.), GenBio(Canada), Hylabs(Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Sartorius AG (Germany), Savyon Diagnostics(Israel), ScienCell Research Laboratories, Inc.(Canada)

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 12.2. MERCK KGAA
  • 12.3. LONZA GROUP LTD.
  • 12.4. ROCHE DIAGNOSTICS (DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
  • 12.5. SGS S.A.
  • 12.6. THERMO FISHER SCIENTIFIC INC.
  • 12.7. AMERICAN TYPE CULTURE COLLECTION
  • 12.8. BIOUNIQUE TESTING LABORATORIES INC.
  • 12.9. INVIVOGEN
  • 12.10. PROMOCELL GMBH
  • 12.11. BIOLOGICAL INDUSTRIES ISRAEL BEIT HAEMEK LTD.
  • 12.12. WUXI APPTEC
  • 12.13. NORGEN BIOTEK CORPORATION

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INDUSTRY INSIGHTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MYCOPLASMA TESTING: MARKET SNAPSHOT
  • TABLE 2: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 3: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY TYPE, 2015-2022(USD MILLION)
  • TABLE 4: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: PCR ASSAYS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NUCLEIC ACID DETECTION KITS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: ELIMINATION KITS & REAGENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: MYCOPLASMA TESTING STAINS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: STANDARDS & CONTROLS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: OTHER KITS & REAGENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MYCOPLASMA TESTING INSTRUMENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: MYCOPLASMA TESTING SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 14: MYCOPLASMA TESTING MARKET SIZE FOR PCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: ELISA METHOD MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: DIRECT ASSAYS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: INDIRECT ASSAYS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: DNA STAINING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: MICROBIAL CULTURE TECHNIQUES MARKET SIZE, BY REGION, 2015- 2022 (USD MILLION)
  • TABLE 20: ENZYMATIC METHODS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: MYCOPLASMA TESTING MARKET SIZE FOR CELL LINE TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: MYCOPLASMA TESTING MARKET SIZE FOR VIRUS TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: MYCOPLASMA TESTING MARKET SIZE FOR END-OF-PRODUCTION CELL TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: OTHER MYCOPLASMA TESTING APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: MYCOPLASMA TESTING MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: MYCOPLASMA TESTING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: MYCOPLASMA TESTING MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: MYCOPLASMA TESTING MARKET SIZE FOR CELL BANKS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: MYCOPLASMA TESTING MARKET SIZE FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: U.S.: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 40: U.S.: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 41: U.S.: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: U.S.: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 43: CANADA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 46: CANADA: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: GERMANY: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 54: U.K.: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 55: FRANCE: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 56: ITALY: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: SPAIN: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA: MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: CHINA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: JAPAN: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 67: INDIA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 68: ROA: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 70: ROW: MYCOPLASMA TESTING KITS & REAGENTS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: ROW: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: ROW: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL MYCOPLASMA TESTING MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MYCOPLASMA TESTING MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT AND SERVICE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: MYCOPLASMA TESTING KITS AND REAGENTS MARKET SIZE, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: MYCOPLASMA TESTING MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 13: GROWING PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES-MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 14: CELL LINE TESTING SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 15: SERVICES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 17: MYCOPLASMA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: KITS & REAGENTS IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE MYCOPLASMA TESTING MARKET IN 2017
  • FIGURE 19: GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNIQUE
  • FIGURE 20: CELL LINE TESTING WILL BE THE FASTEST-GROWING APPLICATION SEGMENT DURNG FORECAST PERIOD
  • FIGURE 21: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE MYCOPLASMA TESTING MARKET IN 2017
  • FIGURE 22: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 23: U.S. TO DOMINATE THE NORTH AMERICAN MYCOPLASMA TESTING MARKET IN 2022
  • FIGURE 24: NORTH AMERICA: MYCOPLASMA TESTING MARKET SNAPSHOT
  • FIGURE 25: EUROPE: MYCOPLASMA TESTING MARKET SNAPSHOT
  • FIGURE 26: GERMANY TO REGISTER THE HIGHEST CAGR IN THE EUROPEAN MYCOPLASMA TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: CHINA WILL CONTINUE TO DOMINATE THE ASIAN MYCOPLASMA TESTING MARKET IN 2022
  • FIGURE 28: ASIA: MYCOPLASMA TESTING MARKET SNAPSHOT
  • FIGURE 29: ROW: MYCOPLASMA TESTING MARKET SNAPSHOT
  • FIGURE 30: DIVE CHART
  • FIGURE 31: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 33: LONZA GROUP LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 34: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 35: SGS S.A.: COMPANY SNAPSHOT (2016)
  • FIGURE 36: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
Back to Top